Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeBiotech

      Biotech

      BIOVAXYS ANNOUNCES CLOSING OF FIFTH TRANCHE OF PRIVATE PLACEMENT
      Biotech

      BIOVAXYS ANNOUNCES CLOSING OF FIFTH TRANCHE OF PRIVATE PLACEMENT

      October 5, 2024
      FDA Roundup: October 4, 2024
      Biotech

      FDA Roundup: October 4, 2024

      October 5, 2024
      Charles Dadswell to step down as General Counsel, Illumina initiates search for successor
      Biotech

      Charles Dadswell to step down as General Counsel, Illumina initiates search for successor

      October 4, 2024
      Enzyme-Linked Immunosorbent Assay (ELISA) Market to Grow by USD 843.9 Million (2024-2028) as AI Drives Demand for Frequent Diagnostic Testing
      Biotech

      Enzyme-Linked Immunosorbent Assay (ELISA) Market to Grow by USD 843.9 Million (2024-2028) as AI Drives Demand for Frequent Diagnostic Testing

      October 4, 2024
      IDEAYA Biosciences Announces Late-Breaker Oral Presentation of IDE397 Phase 1 Expansion Results in MTAP-Deletion Lung and Urothelial Cancer at the 36th Edition of the EORTC-NCI-AACR Symposium
      Biotech

      IDEAYA Biosciences Announces Late-Breaker Oral Presentation of IDE397 Phase 1 Expansion Results in MTAP-Deletion Lung and Urothelial Cancer at the 36th Edition of the EORTC-NCI-AACR Symposium

      October 4, 2024
      IDEAYA Biosciences Announces Late-Breaker Oral Presentation of IDE397 Phase 1 Expansion Results in MTAP-Deletion Lung and Urothelial Cancer at the 36th Edition of the EORTC-NCI-AACR Symposium
      Biotech

      IDEAYA Biosciences Announces Late-Breaker Oral Presentation of IDE397 Phase 1 Expansion Results in MTAP-Deletion Lung and Urothelial Cancer at the 36th Edition of the EORTC-NCI-AACR Symposium

      October 4, 2024
      Resolution Therapeutics Announces £63.5 Million Series B Financing and Chair Appointment
      Biotech

      Resolution Therapeutics Announces £63.5 Million Series B Financing and Chair Appointment

      October 3, 2024
      Expert Systems Celebrates Milestone in Clinical Development of Ratutrelvir, Potential Best-in-Class COVID Candidate
      Biotech

      Expert Systems Celebrates Milestone in Clinical Development of Ratutrelvir, Potential Best-in-Class COVID Candidate

      October 3, 2024
      GenoPalate Unveils Major Upgrade with Enhanced Food Index – Revolutionizing Personalized Nutrition
      Biotech

      GenoPalate Unveils Major Upgrade with Enhanced Food Index – Revolutionizing Personalized Nutrition

      October 3, 2024
      AstronauTx appoints Jane Rhodes as Chief Executive Officer and Expands Executive Team
      Biotech

      AstronauTx appoints Jane Rhodes as Chief Executive Officer and Expands Executive Team

      October 1, 2024
      « 1 … 74 75 76 77 78 … 139 »

       

      LATEST NEWS

      • Health Sanofi Market Potential Boosted by Amvuttra Data

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026